{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cannabidiol", "cannabis", "drugs", "tetrahydrocannabinol"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38067416", "DateCompleted": {"Year": "2023", "Month": "12", "Day": "16"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "21"}], "Language": ["eng"], "ELocationID": ["7686", "10.3390/molecules28237686"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "23", "PubDate": {"Year": "2023", "Month": "Nov", "Day": "21"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Cannabis as a Source of Approved Drugs: A New Look at an Old Problem.", "Abstract": {"AbstractText": ["Cannabis plants have been used in medicine since ancient times. They are well known for their anti-diabetic, anti-inflammatory, neuroprotective, anti-cancer, anti-oxidative, anti-microbial, anti-viral, and anti-fungal activities. A growing body of evidence indicates that targeting the endocannabinoid system and various other receptors with cannabinoid compounds holds great promise for addressing multiple medical conditions. There are two distinct avenues in the development of cannabinoid-based drugs. The first involves creating treatments directly based on the components of the cannabis plant. The second involves a singular molecule strategy, in which specific phytocannabinoids or newly discovered cannabinoids with therapeutic promise are pinpointed and synthesized for future pharmaceutical development and validation. Although the therapeutic potential of cannabis is enormous, few cannabis-related approved drugs exist, and this avenue warrants further investigation. With this in mind, we review here the medicinal properties of cannabis, its phytochemicals, approved drugs of natural and synthetic origin, pitfalls on the way to the widespread clinical use of cannabis, and additional applications of cannabis-related products."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Department of Clinical Biochemistry & Pharmacology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel."}], "LastName": "Gabarin", "ForeName": "Adi", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Department of Clinical Biochemistry & Pharmacology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel."}], "LastName": "Yarmolinsky", "ForeName": "Ludmila", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research and Development Authority, Barzilai University Medical Center, Ashkelon 7830604, Israel."}], "LastName": "Budovsky", "ForeName": "Arie", "Initials": "A"}, {"Identifier": ["0000-0003-1695-6544"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Department of Clinical Biochemistry & Pharmacology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel."}], "LastName": "Khalfin", "ForeName": "Boris", "Initials": "B"}, {"Identifier": ["0000-0001-7551-5488"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Department of Clinical Biochemistry & Pharmacology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel."}], "LastName": "Ben-Shabat", "ForeName": "Shimon", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cannabinoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Cannabinoid Receptor Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Endocannabinoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Hallucinogens"}, {"RegistryNumber": "19GBJ60SN5", "NameOfSubstance": "Cannabidiol"}, {"RegistryNumber": "7J8897W37S", "NameOfSubstance": "Dronabinol"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Cannabis"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Cannabinoids"}, {"QualifierName": [], "DescriptorName": "Cannabinoid Receptor Agonists"}, {"QualifierName": [], "DescriptorName": "Endocannabinoids"}, {"QualifierName": [], "DescriptorName": "Hallucinogens"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Cannabidiol"}, {"QualifierName": [], "DescriptorName": "Dronabinol"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Klionsky D.J., Abdel-Aziz A.K., Abdelfatah S., Abdellatif M., Abdoli A., Abel S., Abeliovich H., Abildgaard M.H., Abudu Y.P., Acevedo-Arozena A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) Autophagy. 2021;17:1\u2013382. doi: 10.1080/15548627.2020.1797280.", "ArticleIdList": ["10.1080/15548627.2020.1797280", "PMC7996087", "33634751"]}, {"Citation": "Li H.-L. An archaeological and historical account of cannabis in China. Econ. Bot. 1973;28:437\u2013448. doi: 10.1007/BF02862859.", "ArticleIdList": ["10.1007/BF02862859"]}, {"Citation": "Bonini S.A., Premoli M., Tambaro S., Kumar A., Maccarinelli G., Memo M., Mastinu A. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J. Ethnopharmacol. 2018;227:300\u2013315. doi: 10.1016/j.jep.2018.09.004.", "ArticleIdList": ["10.1016/j.jep.2018.09.004", "30205181"]}, {"Citation": "Sommano S.R., Chittasupho C., Ruksiriwanich W., Jantrawut P. The Cannabis Terpenes. Molecules. 2020;25:5792. doi: 10.3390/molecules25245792.", "ArticleIdList": ["10.3390/molecules25245792", "PMC7763918", "33302574"]}, {"Citation": "Alves V.L., Gon\u00e7alves J.L., Aguiar J., Teixeira H.M., C\u00e2mara J.S. The synthetic cannabinoids phenomenon: From structure to toxicological properties. A review. Crit. Rev. Toxicol. 2020;50:359\u2013382. doi: 10.1080/10408444.2020.1762539.", "ArticleIdList": ["10.1080/10408444.2020.1762539", "32530350"]}, {"Citation": "Winters K.C., Waldron H., Hops H., Ozechowski T., Montano A. Brief Interventions for Cannabis Using Adolescents. Child Adolesc. Psychiatr. Clin. N. Am. 2023;32:127\u2013140. doi: 10.1016/j.chc.2022.06.004.", "ArticleIdList": ["10.1016/j.chc.2022.06.004", "36410899"]}, {"Citation": "Riggs P., Hinckley J.D., Ross J.M. Addressing Cannabis Use During Adolescence. Child Adolesc. Psychiatr. Clin. N. Am. 2023;32:xiii\u2013xv. doi: 10.1016/j.chc.2022.08.003.", "ArticleIdList": ["10.1016/j.chc.2022.08.003", "36410909"]}, {"Citation": "Johnson-Ferguson L., Di Forti M. From heavy cannabis use to psychosis: Is it time to take action? Ir. J. Psychol. Med. 2023;40:13\u201318. doi: 10.1017/ipm.2021.33.", "ArticleIdList": ["10.1017/ipm.2021.33", "34039454"]}, {"Citation": "Grotenhermen F., M\u00fcller-Vahl K. Medicinal Uses of Marijuana and Cannabinoids. CRC Crit. Rev. Plant Sci. 2016;35:378\u2013405. doi: 10.1080/07352689.2016.1265360.", "ArticleIdList": ["10.1080/07352689.2016.1265360"]}, {"Citation": "Hill K.P. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. JAMA. 2015;313:2474\u20132483. doi: 10.1001/jama.2015.6199.", "ArticleIdList": ["10.1001/jama.2015.6199", "26103031"]}, {"Citation": "Johnson R. Hemp as an Agricultural Commodity. Congressional Research Service; Washington, DC, USA: 2013."}, {"Citation": "Hasan M.A., Hussain M.H., Chowdhury A.S., Dhar S.B., Abedin M., Fima I.N. Computational identification of potential microRNAs and their targets from expressed sequence tags of marijuana (Cannabis sativa) Meta Gene. 2016;10:45\u201355. doi: 10.1016/j.mgene.2016.10.002.", "ArticleIdList": ["10.1016/j.mgene.2016.10.002"]}, {"Citation": "Acosta A., Li L., Weaver M., Capote R., Perr J., Almirall J. Validation of a combined Fast blue BB and 4-Aminophenol colorimetric test for indication of Hemp-type and Marijuana-type cannabis. Forensic Chem. 2022;31:100448. doi: 10.1016/j.forc.2022.100448.", "ArticleIdList": ["10.1016/j.forc.2022.100448"]}, {"Citation": "ElSohly M.A., Radwan M.M., Gul W., Chandra S., Galal A. Phytochemistry of Cannabis sativa L. Prog. Chem. Org. Nat. Prod. 2017;103:1\u201336. doi: 10.1007/978-3-319-45541-9_1.", "ArticleIdList": ["10.1007/978-3-319-45541-9_1", "28120229"]}, {"Citation": "Peng H., Shahidi F. Cannabis and Cannabis Edibles: A Review. J. Agric. Food Chem. 2021;69:1751\u20131774. doi: 10.1021/acs.jafc.0c07472.", "ArticleIdList": ["10.1021/acs.jafc.0c07472", "33555188"]}, {"Citation": "Atalay S., Jarocka-Karpowicz I., Skrzydlewska E. Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants. 2019;9:21. doi: 10.3390/antiox9010021.", "ArticleIdList": ["10.3390/antiox9010021", "PMC7023045", "31881765"]}, {"Citation": "Peyravian N., Deo S., Daunert S., Jimenez J.J. The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne. J. Inflamm. Res. 2022;15:2795\u20132801. doi: 10.2147/JIR.S355489.", "ArticleIdList": ["10.2147/JIR.S355489", "PMC9078861", "35535052"]}, {"Citation": "Carvalho A.C.A.D., Souza G.A.D., Marqui S.V.D., Guiguer \u00c9.L., Ara\u00fajo A.C., Rubira C.J., Goulart R.D.A., Flato U.A.P., Bueno P.C.D.S., Buchaim R.L., et al. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse. Int. J. Mol. Sci. 2020;21:2940. doi: 10.3390/ijms21082940.", "ArticleIdList": ["10.3390/ijms21082940", "PMC7215817", "32331305"]}, {"Citation": "Kim Y., Kim W., Kim S.-H., Sim K.-S., Kim K.-H., Cho K.-H., Kwon G.-S., Lee J.-B., Kim J.-H. Protective Effects of Hemp (Cannabis sativa) Root Extracts against Insulin-Deficient Diabetes Mellitus in Mice. Molecules. 2023;28:3814. doi: 10.3390/molecules28093814.", "ArticleIdList": ["10.3390/molecules28093814", "PMC10179809", "37175224"]}, {"Citation": "Borgonetti V., Biagi M., Galeotti N., Manetti F., Governa P. Investigation on the neuroprotective effect of a cannabidiol-enriched non-psychotropic Cannabis sativa L. extract in an in vitro model of excitotoxicity. Fitoterapia. 2022;163:105315. doi: 10.1016/j.fitote.2022.105315.", "ArticleIdList": ["10.1016/j.fitote.2022.105315", "36179898"]}, {"Citation": "Prakash S., Carter W.G. The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson\u2019s Disease: A Systematic Literature Review of Pre-Clinical Studies. Brain Sci. 2021;11:1573. doi: 10.3390/brainsci11121573.", "ArticleIdList": ["10.3390/brainsci11121573", "PMC8699487", "34942876"]}, {"Citation": "Tomko A.M., Whynot E.G., Ellis L.D., Dupr\u00e9 D.J. Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis. Cancers. 2020;12:1985. doi: 10.3390/cancers12071985.", "ArticleIdList": ["10.3390/cancers12071985", "PMC7409346", "32708138"]}, {"Citation": "McAllister S.D., Abood M.E., Califano J., Guzm\u00e1n M. Cannabinoid Cancer Biology and Prevention. J. Natl. Cancer Inst. Monogr. 2021;2021:99\u2013106. doi: 10.1093/jncimonographs/lgab008.", "ArticleIdList": ["10.1093/jncimonographs/lgab008", "34850900"]}, {"Citation": "Seltzer E.S., Watters A.K., MacKenzie D.J., Granat L.M., Zhang D. Cannabidiol (CBD) as a Promising Anti-Cancer Drug. Cancers. 2020;12:3203. doi: 10.3390/cancers12113203.", "ArticleIdList": ["10.3390/cancers12113203", "PMC7693730", "33143283"]}, {"Citation": "Russo F., Tolomeo F., Vandelli M.A., Biagini G., Paris R., Fulvio F., Lagan\u00e0 A., Capriotti A.L., Carbone L., Gigli G., et al. Kynurenine and kynurenic acid: Two human neuromodulators found in Cannabis sativa L. J. Pharm. Biomed. Anal. 2022;211:114636. doi: 10.1016/j.jpba.2022.114636.", "ArticleIdList": ["10.1016/j.jpba.2022.114636", "35124451"]}, {"Citation": "Barak T., Sharon E., Steinberg D., Feldman M., Sionov R.V., Shalish M. Anti-Bacterial Effect of Cannabidiol against the Cariogenic Streptococcus mutans Bacterium: An In Vitro Study. Int. J. Mol. Sci. 2022;23:15878. doi: 10.3390/ijms232415878.", "ArticleIdList": ["10.3390/ijms232415878", "PMC9782013", "36555519"]}, {"Citation": "De Vita S., Finamore C., Chini M.G., Saviano G., De Felice V., De Marino S., Lauro G., Casapullo A., Fantasma F., Trombetta F., et al. Phytochemical Analysis of the Methanolic Extract and Essential Oil from Leaves of Industrial Hemp Futura 75 Cultivar: Isolation of a New Cannabinoid Derivative and Biological Profile Using Computational Approaches. Plants. 2022;11:1671. doi: 10.3390/plants11131671.", "ArticleIdList": ["10.3390/plants11131671", "PMC9269227", "35807623"]}, {"Citation": "Sionov R.V., Steinberg D. Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light ofAnti-Bacterial Effect of Cannabidiol against the Cariogenic Streptococcus mutans Bacterium: An In Vitro StudyTheir Physiological and Pathophysiological Roles. Biomedicines. 2022;10:631. doi: 10.3390/biomedicines10030631.", "ArticleIdList": ["10.3390/biomedicines10030631", "PMC8945038", "35327432"]}, {"Citation": "Milloy M.-J., Marshall B., Kerr T., Richardson L., Hogg R., Guillemi S., Montaner J.S.G., Wood E. High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. Drug Alcohol Rev. 2015;34:135\u2013140. doi: 10.1111/dar.12223.", "ArticleIdList": ["10.1111/dar.12223", "PMC4363114", "25389027"]}, {"Citation": "Glodowska M. Cannabis sativa L. and Its Antimicrobial Properties\u2014A Review. Institute of Soil Science and Plant Cultivation\u2014State Research Institute; Pulawy, Poland: 2016."}, {"Citation": "Pattnaik F., Nanda S., Mohanty S., Dalai A.K., Kumar V., Ponnusamy S.K., Naik S. Cannabis: Chemistry, extraction and therapeutic applications. Chemosphere. 2022;289:133012. doi: 10.1016/j.chemosphere.2021.133012.", "ArticleIdList": ["10.1016/j.chemosphere.2021.133012", "34838836"]}, {"Citation": "Thomas B.F., ElSohly M.A. The Analytical Chemistry of Cannabis. Elsevier; Amsterdam, The Netherlands: 2016. Biosynthesis and Pharmacology of Phytocannabinoids and Related Chemical Constituents; pp. 27\u201341."}, {"Citation": "Mullins M. Defining recent cannabis use analytically. Clin. Toxicol. 2023;61:324\u2013325. doi: 10.1080/15563650.2023.2210404.", "ArticleIdList": ["10.1080/15563650.2023.2210404", "37293899"]}, {"Citation": "Shapira A., Berman P., Futoran K., Guberman O., Meiri D. Tandem Mass Spectrometric Quantification of 93 Terpenoids in Cannabis Using Static Headspace Injections. Anal. Chem. 2019;91:11425\u201311432. doi: 10.1021/acs.analchem.9b02844.", "ArticleIdList": ["10.1021/acs.analchem.9b02844", "31369251"]}, {"Citation": "Hochma E., Yarmolinsky L., Khalfin B., Nisnevitch M., Ben-Shabat S., Nakonechny F. Antimicrobial Effect of Phytochemicals from Edible Plants. Processes. 2021;9:2089. doi: 10.3390/pr9112089.", "ArticleIdList": ["10.3390/pr9112089"]}, {"Citation": "Greco W.R., Faessel H., Levasseur L. The search for cytotoxic synergy between anticancer agents: A case of Dorothy and the ruby slippers? J. Natl. Cancer Inst. 1996;88:699\u2013700. doi: 10.1093/jnci/88.11.699.", "ArticleIdList": ["10.1093/jnci/88.11.699", "8637018"]}, {"Citation": "Miyazawa M., Yamafuji C. Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids. J. Agric. Food Chem. 2005;53:1765\u20131768. doi: 10.1021/jf040019b.", "ArticleIdList": ["10.1021/jf040019b", "15740071"]}, {"Citation": "Stotz S.C., Vriens J., Martyn D., Clardy J., Clapham D.E. Citral sensing by Transient [corrected] receptor potential channels in dorsal root ganglion neurons. PLoS ONE. 2008;3:e2082. doi: 10.1371/annotation/6ba8e9d9-0035-405e-a7c7-45ee22b2e381.", "ArticleIdList": ["10.1371/annotation/6ba8e9d9-0035-405e-a7c7-45ee22b2e381", "PMC2346451", "18461159"]}, {"Citation": "Schlosburg J.E., Boger D.L., Cravatt B.F., Lichtman A.H. Endocannabinoid modulation of scratching response in an acute allergenic model: A new prospective neural therapeutic target for pruritus. J. Pharmacol. Exp. Ther. 2009;329:314\u2013323. doi: 10.1124/jpet.108.150136.", "ArticleIdList": ["10.1124/jpet.108.150136", "PMC2670585", "19168707"]}, {"Citation": "Schlosburg J.E., O\u2019Neal S.T., Conrad D.H., Lichtman A.H. CB1 receptors mediate rimonabant-induced pruritic responses in mice: Investigation of locus of action. Psychopharmacology. 2011;216:323\u2013331. doi: 10.1007/s00213-011-2224-5.", "ArticleIdList": ["10.1007/s00213-011-2224-5", "PMC3606913", "21340468"]}, {"Citation": "Wagner H., Ulrich-Merzenich G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16:97\u2013110. doi: 10.1016/j.phymed.2008.12.018.", "ArticleIdList": ["10.1016/j.phymed.2008.12.018", "19211237"]}, {"Citation": "Ghasemi-Gojani E., Kovalchuk I., Kovalchuk O. Cannabinoids and terpenes for diabetes mellitus and its complications: From mechanisms to new therapies. Trends Endocrinol. Metab. 2022;33:828\u2013849. doi: 10.1016/j.tem.2022.08.003.", "ArticleIdList": ["10.1016/j.tem.2022.08.003", "36280497"]}, {"Citation": "Ben-Shabat S., Fride E., Sheskin T., Tamiri T., Rhee M.H., Vogel Z., Bisogno T., De Petrocellis L., Di Marzo V., Mechoulam R. An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur. J. Pharmacol. 1998;353:23\u201331. doi: 10.1016/S0014-2999(98)00392-6.", "ArticleIdList": ["10.1016/S0014-2999(98)00392-6", "9721036"]}, {"Citation": "Russo E.B. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br. J. Pharmacol. 2011;163:1344\u20131364. doi: 10.1111/j.1476-5381.2011.01238.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01238.x", "PMC3165946", "21749363"]}, {"Citation": "Mechoulam R., Ben-Shabat S. From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: The ongoing story of cannabis. Nat. Prod. Rep. 1999;16:131\u2013143. doi: 10.1039/a703973e.", "ArticleIdList": ["10.1039/a703973e", "10331283"]}, {"Citation": "Koltai H., Poulin P., Namdar D. Promoting cannabis products to pharmaceutical drugs. Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci. 2019;132:118\u2013120. doi: 10.1016/j.ejps.2019.02.027.", "ArticleIdList": ["10.1016/j.ejps.2019.02.027", "30851400"]}, {"Citation": "Lu H.-C., Mackie K. Review of the Endocannabinoid System. Biol. Psychiatry Cogn. Neurosci. Neuroimaging. 2021;6:607\u2013615. doi: 10.1016/j.bpsc.2020.07.016.", "ArticleIdList": ["10.1016/j.bpsc.2020.07.016", "PMC7855189", "32980261"]}, {"Citation": "Keimpema E., H\u00f6kfelt T., Harkany T., Doherty P. The molecular interplay between endocannabinoid and neurotrophin signals in the nervous system and beyond. Eur. J. Neurosci. 2014;39:334\u2013343. doi: 10.1111/ejn.12431.", "ArticleIdList": ["10.1111/ejn.12431", "24494674"]}, {"Citation": "Pertwee R.G. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin. Br. J. Pharmacol. 2008;153:199\u2013215. doi: 10.1038/sj.bjp.0707442.", "ArticleIdList": ["10.1038/sj.bjp.0707442", "PMC2219532", "17828291"]}, {"Citation": "Cuddihey H., MacNaughton W.K., Sharkey K.A. Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis. Cell. Mol. Gastroenterol. Hepatol. 2022;14:947\u2013963. doi: 10.1016/j.jcmgh.2022.05.015.", "ArticleIdList": ["10.1016/j.jcmgh.2022.05.015", "PMC9500439", "35750314"]}, {"Citation": "Cristino L., Bisogno T., Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat. Rev. Neurol. 2020;16:9\u201329. doi: 10.1038/s41582-019-0284-z.", "ArticleIdList": ["10.1038/s41582-019-0284-z", "31831863"]}, {"Citation": "Radwan M.M., Chandra S., Gul S., ElSohly M.A. Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis. Molecules. 2021;26:2774. doi: 10.3390/molecules26092774.", "ArticleIdList": ["10.3390/molecules26092774", "PMC8125862", "34066753"]}, {"Citation": "Giuffrida A., Beltramo M., Piomelli D. Mechanisms of endocannabinoid inactivation: Biochemistry and pharmacology. J. Pharmacol. Exp. Ther. 2001;298:7\u201314.", "ArticleIdList": ["11408519"]}, {"Citation": "Castillo P.E., Younts T.J., Ch\u00e1vez A.E., Hashimotodani Y. Endocannabinoid signaling and synaptic function. Neuron. 2012;76:70\u201381. doi: 10.1016/j.neuron.2012.09.020.", "ArticleIdList": ["10.1016/j.neuron.2012.09.020", "PMC3517813", "23040807"]}, {"Citation": "Peters K.Z., Cheer J.F., Tonini R. Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System. Trends Neurosci. 2021;44:464\u2013477. doi: 10.1016/j.tins.2021.02.001.", "ArticleIdList": ["10.1016/j.tins.2021.02.001", "PMC8159866", "33674134"]}, {"Citation": "Aizpurua-Olaizola O., Elezgarai I., Rico-Barrio I., Zarandona I., Etxebarria N., Usobiaga A. Targeting the endocannabinoid system: Future therapeutic strategies. Drug Discov. Today. 2017;22:105\u2013110. doi: 10.1016/j.drudis.2016.08.005.", "ArticleIdList": ["10.1016/j.drudis.2016.08.005", "27554802"]}, {"Citation": "Mackie K. Cannabinoid receptors: Where they are and what they do. J. Neuroendocrinol. 2008;20((Suppl. S1)):10\u201314. doi: 10.1111/j.1365-2826.2008.01671.x.", "ArticleIdList": ["10.1111/j.1365-2826.2008.01671.x", "18426493"]}, {"Citation": "Morales P., Reggio P.H. An Update on Non-CB(1), Non-CB(2) Cannabinoid Related G-Protein-Coupled Receptors. Cannabis Cannabinoid Res. 2017;2:265\u2013273. doi: 10.1089/can.2017.0036.", "ArticleIdList": ["10.1089/can.2017.0036", "PMC5665501", "29098189"]}, {"Citation": "Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002;54:161\u2013202. doi: 10.1124/pr.54.2.161.", "ArticleIdList": ["10.1124/pr.54.2.161", "12037135"]}, {"Citation": "Pacher P., Kunos G. Modulating the endocannabinoid system in human health and disease\u2014Successes and failures. FEBS J. 2013;280:1918\u20131943. doi: 10.1111/febs.12260.", "ArticleIdList": ["10.1111/febs.12260", "PMC3684164", "23551849"]}, {"Citation": "Pacher P., Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog. Lipid Res. 2011;50:193\u2013211. doi: 10.1016/j.plipres.2011.01.001.", "ArticleIdList": ["10.1016/j.plipres.2011.01.001", "PMC3062638", "21295074"]}, {"Citation": "Di Marzo V. New approaches and challenges to targeting the endocannabinoid system. Nat. Rev. Drug Discov. 2018;17:623\u2013639. doi: 10.1038/nrd.2018.115.", "ArticleIdList": ["10.1038/nrd.2018.115", "30116049"]}, {"Citation": "Brusa P., Baratta F., Collino M., Ben-Shabat S. Editorial: Medicinal Cannabis: Evolution of therapeutic use, future approaches and other implications. Front. Pharmacol. 2022;13:999068. doi: 10.3389/fphar.2022.999068.", "ArticleIdList": ["10.3389/fphar.2022.999068", "PMC9453742", "36091749"]}, {"Citation": "Rice J., Cameron M. Cannabinoids for Treatment of MS Symptoms: State of the Evidence. Curr. Neurol. Neurosci. Rep. 2018;18:50. doi: 10.1007/s11910-018-0859-x.", "ArticleIdList": ["10.1007/s11910-018-0859-x", "29923025"]}, {"Citation": "Yoo H.B., DiMuzio J., Filbey F.M. Interaction of Cannabis Use and Aging: From Molecule to Mind. J. Dual Diagn. 2020;16:140\u2013176. doi: 10.1080/15504263.2019.1665218.", "ArticleIdList": ["10.1080/15504263.2019.1665218", "PMC8177073", "31570066"]}, {"Citation": "Ram\u00edrez B.G., Bl\u00e1zquez C., G\u00f3mez del Pulgar T., Guzm\u00e1n M., de Ceballos M.L. Prevention of Alzheimer\u2019s disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation. J. Neurosci. Off. J. Soc. Neurosci. 2005;25:1904\u20131913. doi: 10.1523/JNEUROSCI.4540-04.2005.", "ArticleIdList": ["10.1523/JNEUROSCI.4540-04.2005", "PMC6726060", "15728830"]}, {"Citation": "Mart\u00edn-Moreno A.M., Brera B., Spuch C., Carro E., Garc\u00eda-Garc\u00eda L., Delgado M., Pozo M.A., Innamorato N.G., Cuadrado A., de Ceballos M.L. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J. Neuroinflammation. 2012;9:8. doi: 10.1186/1742-2094-9-8.", "ArticleIdList": ["10.1186/1742-2094-9-8", "PMC3292807", "22248049"]}, {"Citation": "Fishbein-Kaminietsky M., Gafni M., Sarne Y. Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage. J. Neurosci. Res. 2014;92:1669\u20131677. doi: 10.1002/jnr.23452.", "ArticleIdList": ["10.1002/jnr.23452", "25042014"]}, {"Citation": "Bonnet A.E., Marchalant Y. Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer\u2019s Disease. Aging Dis. 2015;6:400\u2013405. doi: 10.14336/AD.2015.0617.", "ArticleIdList": ["10.14336/AD.2015.0617", "PMC4567222", "26425394"]}, {"Citation": "Carracedo A., Geelen M.J.H., Diez M., Hanada K., Guzm\u00e1n M., Velasco G. Ceramide sensitizes astrocytes to oxidative stress: Protective role of cannabinoids. Biochem. J. 2004;380:435\u2013440. doi: 10.1042/bj20031714.", "ArticleIdList": ["10.1042/bj20031714", "PMC1224177", "14979873"]}, {"Citation": "van den Elsen G.A.H., Ahmed A.I.A., Verkes R.-J., Kramers C., Feuth T., Rosenberg P.B., van der Marck M.A., Olde Rikkert M.G.M. Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial. Neurology. 2015;84:2338\u20132346. doi: 10.1212/WNL.0000000000001675.", "ArticleIdList": ["10.1212/WNL.0000000000001675", "PMC4464746", "25972490"]}, {"Citation": "Passmore M.J. The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation. Int. J. Geriatr. Psychiatry. 2008;23:116\u2013117. doi: 10.1002/gps.1828.", "ArticleIdList": ["10.1002/gps.1828", "18081000"]}, {"Citation": "van den Elsen G.A., Tobben L., Ahmed A.I., Verkes R.J., Kramers C., Marijnissen R.M., Olde Rikkert M.G., van der Marck M.A. Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial. J. Psychopharmacol. 2017;31:184\u2013191. doi: 10.1177/0269881116665357.", "ArticleIdList": ["10.1177/0269881116665357", "27624148"]}, {"Citation": "Cavalli E., Mammana S., Nicoletti F., Bramanti P., Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int. J. Immunopathol. Pharmacol. 2019;33:2058738419838383. doi: 10.1177/2058738419838383.", "ArticleIdList": ["10.1177/2058738419838383", "PMC6431761", "30900486"]}, {"Citation": "Sheriff T., Lin M.J., Dubin D., Khorasani H. The potential role of cannabinoids in dermatology. J. Dermatolog. Treat. 2020;31:839\u2013845. doi: 10.1080/09546634.2019.1675854.", "ArticleIdList": ["10.1080/09546634.2019.1675854", "31599175"]}, {"Citation": "St\u00e4nder S., Schmelz M., Metze D., Luger T., Rukwied R. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J. Dermatol. Sci. 2005;38:177\u2013188. doi: 10.1016/j.jdermsci.2005.01.007.", "ArticleIdList": ["10.1016/j.jdermsci.2005.01.007", "15927811"]}, {"Citation": "Baswan S.M., Klosner A.E., Glynn K., Rajgopal A., Malik K., Yim S., Stern N. Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders. Clin. Cosmet. Investig. Dermatol. 2020;13:927\u2013942. doi: 10.2147/CCID.S286411.", "ArticleIdList": ["10.2147/CCID.S286411", "PMC7736837", "33335413"]}, {"Citation": "Milando R., Friedman A. Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases. Am. J. Clin. Dermatol. 2019;20:167\u2013180. doi: 10.1007/s40257-018-0410-5.", "ArticleIdList": ["10.1007/s40257-018-0410-5", "30542832"]}, {"Citation": "Eagleston L.R.M., Kalani N.K., Patel R.R., Flaten H.K., Dunnick C.A., Dellavalle R.P. Cannabinoids in dermatology: A scoping review. Dermatol. Online J. 2018;24:1\u201317. doi: 10.5070/D3246040706.", "ArticleIdList": ["10.5070/D3246040706", "30142706"]}, {"Citation": "Wilkinson J.D., Williamson E.M. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J. Dermatol. Sci. 2007;45:87\u201392. doi: 10.1016/j.jdermsci.2006.10.009.", "ArticleIdList": ["10.1016/j.jdermsci.2006.10.009", "17157480"]}, {"Citation": "Changoer L., Anastassov G. Method to Treat Psoriasis.  [(accessed on 8 November 2023)];2018 Volume 1:8. Available online:  https://patents.google.com/patent/US20190060250A1/en."}, {"Citation": "Sangiovanni E., Fumagalli M., Pacchetti B., Piazza S., Magnavacca A., Khalilpour S., Melzi G., Martinelli G., Dell\u2019Agli M. Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury. Phytother. Res. 2019;33:2083\u20132093. doi: 10.1002/ptr.6400.", "ArticleIdList": ["10.1002/ptr.6400", "31250491"]}, {"Citation": "Kongkadee K., Wisuitiprot W., Ingkaninan K., Waranuch N. Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study. Arch. Oral Biol. 2022;140:105464. doi: 10.1016/j.archoralbio.2022.105464.", "ArticleIdList": ["10.1016/j.archoralbio.2022.105464", "35623115"]}, {"Citation": "Jin S., Lee M.-Y. The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnes-induced inflammation and lipogenesis in sebocytes. PLoS ONE. 2018;13:e0202933. doi: 10.1371/journal.pone.0202933.", "ArticleIdList": ["10.1371/journal.pone.0202933", "PMC6110517", "30148860"]}, {"Citation": "Martinelli G., Magnavacca A., Fumagalli M., Dell\u2019Agli M., Piazza S., Sangiovanni E. Cannabis sativa and Skin Health: Dissecting the Role of Phytocannabinoids. Planta Med. 2022;88:492\u2013506. doi: 10.1055/a-1420-5780.", "ArticleIdList": ["10.1055/a-1420-5780", "33851375"]}, {"Citation": "Ali A., Akhtar N. The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content. Pak. J. Pharm. Sci. 2015;28:1389\u20131395.", "ArticleIdList": ["26142529"]}, {"Citation": "Hanu\u0161 L.O., Meyer S.M., Mu\u00f1oz E., Taglialatela-Scafati O., Appendino G. Phytocannabinoids: A unified critical inventory. Nat. Prod. Rep. 2016;33:1357\u20131392. doi: 10.1039/C6NP00074F.", "ArticleIdList": ["10.1039/C6NP00074F", "27722705"]}, {"Citation": "Samanta D. Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy. Pediatr. Neurol. 2019;96:24\u201329. doi: 10.1016/j.pediatrneurol.2019.03.014.", "ArticleIdList": ["10.1016/j.pediatrneurol.2019.03.014", "31053391"]}, {"Citation": "Kovalchuk O., Kovalchuk I. Cannabinoids as anticancer therapeutic agents. Cell Cycle. 2020;19:961\u2013989. doi: 10.1080/15384101.2020.1742952.", "ArticleIdList": ["10.1080/15384101.2020.1742952", "PMC7217364", "32249682"]}, {"Citation": "Franco V., Perucca E. Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy. Drugs. 2019;79:1435\u20131454. doi: 10.1007/s40265-019-01171-4.", "ArticleIdList": ["10.1007/s40265-019-01171-4", "31372958"]}, {"Citation": "Silvestro S., Mammana S., Cavalli E., Bramanti P., Mazzon E. Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials. Molecules. 2019;24:1459. doi: 10.3390/molecules24081459.", "ArticleIdList": ["10.3390/molecules24081459", "PMC6514832", "31013866"]}, {"Citation": "Campos A.C., Foga\u00e7a M.V., Sonego A.B., Guimar\u00e3es F.S. Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol. Res. 2016;112:119\u2013127. doi: 10.1016/j.phrs.2016.01.033.", "ArticleIdList": ["10.1016/j.phrs.2016.01.033", "26845349"]}, {"Citation": "Premoli M., Aria F., Bonini S.A., Maccarinelli G., Gianoncelli A., Della Pina S., Tambaro S., Memo M., Mastinu A. Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment. Life Sci. 2019;224:120\u2013127. doi: 10.1016/j.lfs.2019.03.053.", "ArticleIdList": ["10.1016/j.lfs.2019.03.053", "30910646"]}, {"Citation": "Li H., Liu Y., Tian D., Tian L., Ju X., Qi L., Wang Y., Liang C. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer\u2019s disease. Eur. J. Med. Chem. 2020;192:112163. doi: 10.1016/j.ejmech.2020.112163.", "ArticleIdList": ["10.1016/j.ejmech.2020.112163", "32109623"]}, {"Citation": "Pacher P., Kogan N.M., Mechoulam R. Beyond THC and Endocannabinoids. Annu. Rev. Pharmacol. Toxicol. 2020;60:637\u2013659. doi: 10.1146/annurev-pharmtox-010818-021441.", "ArticleIdList": ["10.1146/annurev-pharmtox-010818-021441", "31580774"]}, {"Citation": "Arzimanoglou A., Brandl U., Cross J.H., Gil-Nagel A., Lagae L., Landmark C.J., Specchio N., Nabbout R., Thiele E.A., Gubbay O., et al. Epilepsy and cannabidiol: A guide to treatment. Epileptic Disord. 2020;22:1\u201314. doi: 10.1684/epd.2020.1141.", "ArticleIdList": ["10.1684/epd.2020.1141", "32096470"]}, {"Citation": "Monti M.C., Frei P., Weber S., Scheurer E., Mercer-Chalmers-Bender K. Beyond \u03949-tetrahydrocannabinol and cannabidiol: Chemical differentiation of cannabis varieties applying targeted and untargeted analysis. Anal. Bioanal. Chem. 2022;414:3847\u20133862. doi: 10.1007/s00216-022-04026-2.", "ArticleIdList": ["10.1007/s00216-022-04026-2", "PMC9061671", "35380230"]}, {"Citation": "Pennypacker S.D., Romero-Sandoval E.A. CBD and THC: Do They Complement Each Other Like Yin and Yang? Pharmacotherapy. 2020;40:1152\u20131165. doi: 10.1002/phar.2469.", "ArticleIdList": ["10.1002/phar.2469", "33080058"]}, {"Citation": "La Maida N., Di Giorgi A., Pichini S., Busard\u00f2 F.P., Huestis M.A. Recent challenges and trends in forensic analysis: \u03949-THC isomers pharmacology, toxicology and analysis. J. Pharm. Biomed. Anal. 2022;220:114987. doi: 10.1016/j.jpba.2022.114987.", "ArticleIdList": ["10.1016/j.jpba.2022.114987", "35985136"]}, {"Citation": "European Monitoring Centre for Drugs and Drug Addiction . Low-THC Cannabis Products in Europe. Publications Office of the European Union; Lisbon, Portugal: 2020.", "ArticleIdList": ["10.2810/69625"]}, {"Citation": "Assanangkornchai S., Kalayasiri R., Ratta-Apha W., Tanaree A. Effects of cannabis legalization on the use of cannabis and other substances. Curr. Opin. Psychiatry. 2023;36:283\u2013289. doi: 10.1097/YCO.0000000000000868.", "ArticleIdList": ["10.1097/YCO.0000000000000868", "37185310"]}, {"Citation": "Casanova C., Ramier C., Fortin D., Carrieri P., Mancini J., Barr\u00e9 T. Cannabidiol use and perceptions in France: A national survey. BMC Public Health. 2022;22:1628. doi: 10.1186/s12889-022-14057-0.", "ArticleIdList": ["10.1186/s12889-022-14057-0", "PMC9421113", "36038869"]}, {"Citation": "Morales P., Jagerovic N. Novel approaches and current challenges with targeting the endocannabinoid system. Expert Opin. Drug Discov. 2020;15:917\u2013930. doi: 10.1080/17460441.2020.1752178.", "ArticleIdList": ["10.1080/17460441.2020.1752178", "PMC7502221", "32336154"]}, {"Citation": "Cohen K., Weizman A., Weinstein A. Positive and Negative Effects of Cannabis and Cannabinoids on Health. Clin. Pharmacol. Ther. 2019;105:1139\u20131147. doi: 10.1002/cpt.1381.", "ArticleIdList": ["10.1002/cpt.1381", "30703255"]}, {"Citation": "Urits I., Charipova K., Gress K., Li N., Berger A.A., Cornett E.M., Kassem H., Ngo A.L., Kaye A.D., Viswanath O. Adverse Effects of Recreational and Medical Cannabis. Psychopharmacol. Bull. 2021;51:94\u2013109.", "ArticleIdList": ["PMC8063125", "33897066"]}, {"Citation": "Legare C.A., Raup-Konsavage W.M., Vrana K.E. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. Pharmacology. 2022;107:131\u2013149. doi: 10.1159/000521683.", "ArticleIdList": ["10.1159/000521683", "35093949"]}, {"Citation": "Jacobsen L.K., Mencl W.E., Westerveld M., Pugh K.R. Impact of cannabis use on brain function in adolescents. Ann. N. Y. Acad. Sci. 2004;1021:384\u2013390. doi: 10.1196/annals.1308.053.", "ArticleIdList": ["10.1196/annals.1308.053", "15251914"]}, {"Citation": "Cooper Z.D., Haney M. Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend. 2014;136:85\u201391. doi: 10.1016/j.drugalcdep.2013.12.013.", "ArticleIdList": ["10.1016/j.drugalcdep.2013.12.013", "PMC4518446", "24440051"]}, {"Citation": "Murray R.M., Quigley H., Quattrone D., Englund A., Di Forti M. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: Increasing risk for psychosis. World Psychiatry. 2016;15:195\u2013204. doi: 10.1002/wps.20341.", "ArticleIdList": ["10.1002/wps.20341", "PMC5032490", "27717258"]}, {"Citation": "Testai F.D., Gorelick P.B., Aparicio H.J., Filbey F.M., Gonzalez R., Gottesman R.F., Melis M., Piano M.R., Rubino T., Song S.Y. Use of Marijuana: Effect on Brain Health: A Scientific Statement from the American Heart Association. Stroke. 2022;53:e176\u2013e187. doi: 10.1161/STR.0000000000000396.", "ArticleIdList": ["10.1161/STR.0000000000000396", "35142225"]}, {"Citation": "Burggren A.C., Shirazi A., Ginder N., London E.D. Cannabis effects on brain structure, function, and cognition: Considerations for medical uses of cannabis and its derivatives. Am. J. Drug Alcohol Abus. 2019;45:563\u2013579. doi: 10.1080/00952990.2019.1634086.", "ArticleIdList": ["10.1080/00952990.2019.1634086", "PMC7027431", "31365275"]}, {"Citation": "Fantegrossi W.E., Wilson C.D., Berquist M.D. Pro-psychotic effects of synthetic cannabinoids: Interactions with central dopamine, serotonin, and glutamate systems. Drug Metab. Rev. 2018;50:65\u201373. doi: 10.1080/03602532.2018.1428343.", "ArticleIdList": ["10.1080/03602532.2018.1428343", "PMC6419500", "29385930"]}, {"Citation": "Weinstein A., Livny A., Weizman A. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users. Curr. Pharm. Des. 2016;22:6366\u20136379. doi: 10.2174/1381612822666160822151323.", "ArticleIdList": ["10.2174/1381612822666160822151323", "27549374"]}, {"Citation": "Lorenzetti V., Solowij N., Y\u00fccel M. The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users. Biol. Psychiatry. 2016;79:e17\u2013e31. doi: 10.1016/j.biopsych.2015.11.013.", "ArticleIdList": ["10.1016/j.biopsych.2015.11.013", "26858212"]}, {"Citation": "Grigg J., Manning V., Arunogiri S., Lubman D.I. Synthetic cannabinoid use disorder: An update for general psychiatrists. Australas. Psychiatry Bull. R. Aust. N. Z. Coll. Psychiatr. 2019;27:279\u2013283. doi: 10.1177/1039856218822749.", "ArticleIdList": ["10.1177/1039856218822749", "30663326"]}, {"Citation": "Bl\u00e1zquez C., Ruiz-Calvo A., Bajo-Gra\u00f1eras R., Baufreton J.M., Resel E., Varilh M., Pagano Zottola A.C., Mariani Y., Cannich A., Rodr\u00edguez-Navarro J.A., et al. Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination. eLife. 2020;9:e56811. doi: 10.7554/eLife.56811.", "ArticleIdList": ["10.7554/eLife.56811", "PMC7417168", "32773031"]}, {"Citation": "Boros C.A., Parsons D.W., Zoanetti G.D., Ketteridge D., Kennedy D. Cannabis cookies: A cause of coma. J. Paediatr. Child Health. 1996;32:194\u2013195. doi: 10.1111/j.1440-1754.1996.tb00922.x.", "ArticleIdList": ["10.1111/j.1440-1754.1996.tb00922.x", "9156535"]}, {"Citation": "Di Forti M., Marconi A., Carra E., Fraietta S., Trotta A., Bonomo M., Bianconi F., Gardner-Sood P., O\u2019Connor J., Russo M., et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study. Lancet Psychiatry. 2015;2:233\u2013238. doi: 10.1016/S2215-0366(14)00117-5.", "ArticleIdList": ["10.1016/S2215-0366(14)00117-5", "26359901"]}, {"Citation": "D\u2019Souza D.C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y.-T., Braley G., Gueorguieva R., Krystal J.H. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology. 2004;29:1558\u20131572. doi: 10.1038/sj.npp.1300496.", "ArticleIdList": ["10.1038/sj.npp.1300496", "15173844"]}, {"Citation": "Kalant H. Adverse effects of cannabis on health: An update of the literature since 1996. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2004;28:849\u2013863. doi: 10.1016/j.pnpbp.2004.05.027.", "ArticleIdList": ["10.1016/j.pnpbp.2004.05.027", "15363608"]}, {"Citation": "Gibbs M., Winsper C., Marwaha S., Gilbert E., Broome M., Singh S.P. Cannabis use and mania symptoms: A systematic review and meta-analysis. J. Affect. Disord. 2015;171:39\u201347. doi: 10.1016/j.jad.2014.09.016.", "ArticleIdList": ["10.1016/j.jad.2014.09.016", "25285897"]}, {"Citation": "Bally N., Zullino D., Aubry J.-M. Cannabis use and first manic episode. J. Affect. Disord. 2014;165:103\u2013108. doi: 10.1016/j.jad.2014.04.038.", "ArticleIdList": ["10.1016/j.jad.2014.04.038", "24882185"]}, {"Citation": "Patton G.C., Coffey C., Carlin J.B., Degenhardt L., Lynskey M., Hall W. Cannabis use and mental health in young people: Cohort study. BMJ. 2002;325:1195\u20131198. doi: 10.1136/bmj.325.7374.1195.", "ArticleIdList": ["10.1136/bmj.325.7374.1195", "PMC135489", "12446533"]}, {"Citation": "Breijyeh Z., Jubeh B., Bufo S.A., Karaman R., Scrano L. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses. Toxins. 2021;13:117. doi: 10.3390/toxins13020117.", "ArticleIdList": ["10.3390/toxins13020117", "PMC7915118", "33562446"]}, {"Citation": "Noble M.J., Hedberg K., Hendrickson R.G. Acute cannabis toxicity. Clin. Toxicol. 2019;57:735\u2013742. doi: 10.1080/15563650.2018.1548708.", "ArticleIdList": ["10.1080/15563650.2018.1548708", "30676820"]}, {"Citation": "Thomas G., Kloner R.A., Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: What cardiologists need to know. Am. J. Cardiol. 2014;113:187\u2013190. doi: 10.1016/j.amjcard.2013.09.042.", "ArticleIdList": ["10.1016/j.amjcard.2013.09.042", "24176069"]}, {"Citation": "Dabiri A.E., Kassab G.S. Effects of Cannabis on Cardiovascular System: The Good, the Bad, and the Many Unknowns. Med. Cannabis Cannabinoids. 2021;4:75\u201385. doi: 10.1159/000519775.", "ArticleIdList": ["10.1159/000519775", "PMC8832198", "35224427"]}, {"Citation": "Sachs J., McGlade E., Yurgelun-Todd D. Safety and Toxicology of Cannabinoids. Neurother. J. Am. Soc. Exp. Neurother. 2015;12:735\u2013746. doi: 10.1007/s13311-015-0380-8.", "ArticleIdList": ["10.1007/s13311-015-0380-8", "PMC4604177", "26269228"]}, {"Citation": "Shalata W., Abo Abod M., Golosky M., Boehm Cohen L., Kassirer M., Kamenev I., Raviv Y. Cannabis Vaping-induced Lung Injury. Isr. Med. Assoc. J. 2023;25:360\u2013361.", "ArticleIdList": ["37245106"]}, {"Citation": "Tashkin D.P., Simmons M.S., Tseng C.-H. Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis. COPD. 2012;9:367\u2013374. doi: 10.3109/15412555.2012.671868.", "ArticleIdList": ["10.3109/15412555.2012.671868", "22497563"]}, {"Citation": "Tashkin D.P., Baldwin G.C., Sarafian T., Dubinett S., Roth M.D. Respiratory and immunologic consequences of marijuana smoking. J. Clin. Pharmacol. 2002;42:71S\u201381S. doi: 10.1002/j.1552-4604.2002.tb06006.x.", "ArticleIdList": ["10.1002/j.1552-4604.2002.tb06006.x", "12412839"]}, {"Citation": "Tuvel A.L., Winiger E.A., Ross J.M. A Review of the Effects of Adolescent Cannabis Use on Physical Health. Child Adolesc. Psychiatr. Clin. N. Am. 2023;32:85\u2013105. doi: 10.1016/j.chc.2022.07.005.", "ArticleIdList": ["10.1016/j.chc.2022.07.005", "PMC10165991", "36410908"]}, {"Citation": "Meah F., Lundholm M., Emanuele N., Amjed H., Poku C., Agrawal L., Emanuele M.A. The effects of cannabis and cannabinoids on the endocrine system. Rev. Endocr. Metab. Disord. 2022;23:401\u2013420. doi: 10.1007/s11154-021-09682-w.", "ArticleIdList": ["10.1007/s11154-021-09682-w", "34460075"]}, {"Citation": "Bhatia P., Chen M., Christiansen S. Marijuana and stoned fruit. Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol. 2018;120:536\u2013537. doi: 10.1016/j.anai.2018.01.017.", "ArticleIdList": ["10.1016/j.anai.2018.01.017", "PMC5936671", "29410115"]}, {"Citation": "Damkier P., Lassen D., Christensen M.M.H., Madsen K.G., Hellfritzsch M., Potteg\u00e5rd A. Interaction between warfarin and cannabis. Basic Clin. Pharmacol. Toxicol. 2019;124:28\u201331. doi: 10.1111/bcpt.13152.", "ArticleIdList": ["10.1111/bcpt.13152", "30326170"]}, {"Citation": "Kocis P.T., Vrana K.E. Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Med. Cannabis Cannabinoids. 2020;3:61\u201373. doi: 10.1159/000507998.", "ArticleIdList": ["10.1159/000507998", "PMC8489344", "34676340"]}, {"Citation": "Alsherbiny M.A., Li C.G. Medicinal Cannabis-Potential Drug Interactions. Medicines. 2018;6:3. doi: 10.3390/medicines6010003.", "ArticleIdList": ["10.3390/medicines6010003", "PMC6473892", "30583596"]}, {"Citation": "Cox E.J., Maharao N., Patilea-Vrana G., Unadkat J.D., Rettie A.E., McCune J.S., Paine M.F. A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics. Pharmacol. Ther. 2019;201:25\u201338. doi: 10.1016/j.pharmthera.2019.05.001.", "ArticleIdList": ["10.1016/j.pharmthera.2019.05.001", "PMC6708768", "31071346"]}, {"Citation": "Lopera V., Rodr\u00edguez A., Amariles P. Clinical Relevance of Drug Interactions with Cannabis: A Systematic Review. J. Clin. Med. 2022;11:1154. doi: 10.3390/jcm11051154.", "ArticleIdList": ["10.3390/jcm11051154", "PMC8911401", "35268245"]}, {"Citation": "Thomas T.F., Metaxas E.S., Nguyen T., Bennett W., Skiendzielewski K.V., Quinn D.H., Scaletta A.L. Case report: Medical cannabis-warfarin drug-drug interaction. J. Cannabis Res. 2022;4:6. doi: 10.1186/s42238-021-00112-x.", "ArticleIdList": ["10.1186/s42238-021-00112-x", "PMC8744571", "35012687"]}, {"Citation": "Patridge E., Gareiss P., Kinch M.S., Hoyer D. An analysis of FDA-approved drugs: Natural products and their derivatives. Drug Discov. Today. 2016;21:204\u2013207. doi: 10.1016/j.drudis.2015.01.009.", "ArticleIdList": ["10.1016/j.drudis.2015.01.009", "25617672"]}, {"Citation": "Lucas C.J., Galettis P., Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br. J. Clin. Pharmacol. 2018;84:2477\u20132482. doi: 10.1111/bcp.13710.", "ArticleIdList": ["10.1111/bcp.13710", "PMC6177698", "30001569"]}, {"Citation": "Stella B., Baratta F., Della Pepa C., Arpicco S., Gastaldi D., Dosio F. Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain. Drugs. 2021;81:1513\u20131557. doi: 10.1007/s40265-021-01579-x.", "ArticleIdList": ["10.1007/s40265-021-01579-x", "PMC8417625", "34480749"]}, {"Citation": "Zgair A., Wong J.C., Lee J.B., Mistry J., Sivak O., Wasan K.M., Hennig I.M., Barrett D.A., Constantinescu C.S., Fischer P.M., et al. Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines. Am. J. Transl. Res. 2016;8:3448\u20133459.", "ArticleIdList": ["PMC5009397", "27648135"]}, {"Citation": "Atsmon J., Cherniakov I., Izgelov D., Hoffman A., Domb A.J., Deutsch L., Deutsch F., Heffetz D., Sacks H. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers. J. Pharm. Sci. 2018;107:1423\u20131429. doi: 10.1016/j.xphs.2017.12.020.", "ArticleIdList": ["10.1016/j.xphs.2017.12.020", "29287930"]}, {"Citation": "Bruni N., Della Pepa C., Oliaro-Bosso S., Pessione E., Gastaldi D., Dosio F. Cannabinoid Delivery Systems for Pain and Inflammation Treatment. Molecules. 2018;23:2478. doi: 10.3390/molecules23102478.", "ArticleIdList": ["10.3390/molecules23102478", "PMC6222489", "30262735"]}, {"Citation": "Greish K., Mathur A., Al Zahrani R., Elkaissi S., Al Jishi M., Nazzal O., Taha S., Pittal\u00e0 V., Taurin S. Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer. J. Control. Release. 2018;291:184\u2013195. doi: 10.1016/j.jconrel.2018.10.030.", "ArticleIdList": ["10.1016/j.jconrel.2018.10.030", "30367922"]}, {"Citation": "Nakano Y., Tajima M., Sugiyama E., Sato V.H., Sato H. Development of a Novel Nano-emulsion Formulation to Improve Intestinal Absorption of Cannabidiol. Med. Cannabis Cannabinoids. 2019;2:35\u201342. doi: 10.1159/000497361.", "ArticleIdList": ["10.1159/000497361", "PMC8489317", "34676332"]}, {"Citation": "Fathordoobady F., Sannikova N., Guo Y., Singh A., Kitts D.D., Pratap-Singh A. Comparing microfluidics and ultrasonication as formulation methods for developing hempseed oil nanoemulsions for oral delivery applications. Sci. Rep. 2021;11:72. doi: 10.1038/s41598-020-79161-w.", "ArticleIdList": ["10.1038/s41598-020-79161-w", "PMC7794282", "33420136"]}, {"Citation": "Namdar D., Anis O., Poulin P., Koltai H. Chronological Review and Rational and Future Prospects of Cannabis-Based Drug Development. Molecules. 2020;25:4821. doi: 10.3390/molecules25204821.", "ArticleIdList": ["10.3390/molecules25204821", "PMC7587964", "33092255"]}, {"Citation": "Bennici A., Mannucci C., Calapai F., Cardia L., Ammendolia I., Gangemi S., Calapai G., Griscti Soler D. Safety of Medical Cannabis in Neuropathic Chronic Pain Management. Molecules. 2021;26:6257. doi: 10.3390/molecules26206257.", "ArticleIdList": ["10.3390/molecules26206257", "PMC8540828", "34684842"]}, {"Citation": "Pagano C., Navarra G., Coppola L., Avilia G., Bifulco M., Laezza C. Cannabinoids: Therapeutic Use in Clinical Practice. Int. J. Mol. Sci. 2022;23:3344. doi: 10.3390/ijms23063344.", "ArticleIdList": ["10.3390/ijms23063344", "PMC8952215", "35328765"]}, {"Citation": "Russo E.B., Guy G.W., Robson P.J. Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem. Biodivers. 2007;4:1729\u20131743. doi: 10.1002/cbdv.200790150.", "ArticleIdList": ["10.1002/cbdv.200790150", "17712817"]}, {"Citation": "Lacroix C., Guilhaumou R., Micallef J., Bruneteau G., Desnuelle C., Blin O. Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients\u2019 view? Rev. Neurol. 2023;179:967\u2013974. doi: 10.1016/j.neurol.2023.03.018.", "ArticleIdList": ["10.1016/j.neurol.2023.03.018", "37460332"]}, {"Citation": "Trecki J., Gerona R.R., Schwartz M.D. Synthetic Cannabinoid-Related Illnesses and Deaths. N. Engl. J. Med. 2015;373:103\u2013107. doi: 10.1056/NEJMp1505328.", "ArticleIdList": ["10.1056/NEJMp1505328", "26154784"]}, {"Citation": "Banister S.D., Connor M. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins. Handb. Exp. Pharmacol. 2018;252:165\u2013190. doi: 10.1007/164_2018_143.", "ArticleIdList": ["10.1007/164_2018_143", "29980914"]}, {"Citation": "Castaneto M.S., Gorelick D.A., Desrosiers N.A., Hartman R.L., Pirard S., Huestis M.A. Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;144:12\u201341. doi: 10.1016/j.drugalcdep.2014.08.005.", "ArticleIdList": ["10.1016/j.drugalcdep.2014.08.005", "PMC4253059", "25220897"]}, {"Citation": "ElSohly M.A., Ahmed S., Gul S.W., Gul W. Critical Issues in Alcohol and Drugs of Abuse Testing. Academic Press; Cambridge, MA, USA: 2023. Review of Synthetic Cannabinoids on the Illicit Drug Market; pp. 273\u2013319. Chapter 22."}, {"Citation": "Winstock A.R., Barratt M.J. Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug Alcohol Depend. 2013;131:106\u2013111. doi: 10.1016/j.drugalcdep.2012.12.011.", "ArticleIdList": ["10.1016/j.drugalcdep.2012.12.011", "23291209"]}, {"Citation": "Sachdev S., Vemuri K., Banister S.D., Longworth M., Kassiou M., Santiago M., Makriyannis A., Connor M. In vitro determination of the efficacy of illicit synthetic cannabinoids at CB(1) receptors. Br. J. Pharmacol. 2019;176:4653\u20134665. doi: 10.1111/bph.14829.", "ArticleIdList": ["10.1111/bph.14829", "PMC6965679", "31412133"]}, {"Citation": "Gamage T.F., Farquhar C.E., Lefever T.W., Marusich J.A., Kevin R.C., McGregor I.S., Wiley J.L., Thomas B.F. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA. J. Pharmacol. Exp. Ther. 2018;365:437\u2013446. doi: 10.1124/jpet.117.246983.", "ArticleIdList": ["10.1124/jpet.117.246983", "PMC5932312", "29549157"]}, {"Citation": "Silva J.P., Ara\u00fajo A.M., de Pinho P.G., Carmo H., Carvalho F. Synthetic Cannabinoids JWH-122 and THJ-2201 Disrupt Endocannabinoid-Regulated Mitochondrial Function and Activate Apoptotic Pathways as a Primary Mechanism of In Vitro Nephrotoxicity at In Vivo Relevant Concentrations. Toxicol. Sci. 2019;169:422\u2013435. doi: 10.1093/toxsci/kfz050.", "ArticleIdList": ["10.1093/toxsci/kfz050", "30796436"]}, {"Citation": "Alp A., Akdam H., Avc\u0131o\u011flu B.Y., Ersan S. Synthetic cannabinoids in the kidneys. Rev. Assoc. Med. Bras. 2017;63:10\u201312. doi: 10.1590/1806-9282.63.01.10.", "ArticleIdList": ["10.1590/1806-9282.63.01.10", "28225877"]}, {"Citation": "Iversen L. Cannabis and the brain. Brain. 2003;126:1252\u20131270. doi: 10.1093/brain/awg143.", "ArticleIdList": ["10.1093/brain/awg143", "12764049"]}, {"Citation": "Mittleman M.A., Lewis R.A., Maclure M., Sherwood J.B., Muller J.E. Triggering myocardial infarction by marijuana. Circulation. 2001;103:2805\u20132809. doi: 10.1161/01.CIR.103.23.2805.", "ArticleIdList": ["10.1161/01.CIR.103.23.2805", "11401936"]}, {"Citation": "Raheemullah A., Laurence T.N. Repeated Thrombosis after Synthetic Cannabinoid Use. J. Emerg. Med. 2016;51:540\u2013543. doi: 10.1016/j.jemermed.2016.06.015.", "ArticleIdList": ["10.1016/j.jemermed.2016.06.015", "27595371"]}, {"Citation": "Orsini J., Blaak C., Tam E., Rajayer S., Morante J., Yeh A., Butala A. The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity. Case Rep. Crit. Care. 2015;2015:542490. doi: 10.1155/2015/542490.", "ArticleIdList": ["10.1155/2015/542490", "PMC4691597", "26788376"]}, {"Citation": "Trezza V., Campolongo P., Cassano T., Macheda T., Dipasquale P., Carrat\u00f9 M.R., Gaetani S., Cuomo V. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: A longitudinal behavioral study in Wistar rats. Psychopharmacology. 2008;198:529\u2013537. doi: 10.1007/s00213-008-1162-3.", "ArticleIdList": ["10.1007/s00213-008-1162-3", "18452035"]}, {"Citation": "Bernson-Leung M.E., Leung L.Y., Kumar S. Synthetic cannabis and acute ischemic stroke. J. Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc. 2014;23:1239\u20131241. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.030.", "ArticleIdList": ["10.1016/j.jstrokecerebrovasdis.2013.07.030", "24119618"]}, {"Citation": "Norman C., Walker G., McKirdy B., McDonald C., Fletcher D., Antonides L.H., Sutcliffe O.B., Nic Da\u00e9id N., McKenzie C. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market. Drug Test. Anal. 2020;12:538\u2013554. doi: 10.1002/dta.2767.", "ArticleIdList": ["10.1002/dta.2767", "31944624"]}, {"Citation": "Spindle T.R., Sholler D.J., Cone E.J., Murphy T.P., ElSohly M., Winecker R.E., Flegel R.R., Bonn-Miller M.O., Vandrey R. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores. JAMA Netw. Open. 2022;5:e2223019. doi: 10.1001/jamanetworkopen.2022.23019.", "ArticleIdList": ["10.1001/jamanetworkopen.2022.23019", "PMC9301515", "35857320"]}, {"Citation": "Votrubec C., Tran P., Lei A., Brunet Z., Bean L., Olsen B.W., Sharma D. Cannabinoid therapeutics in orofacial pain management: A systematic review. Aust. Dent. J. 2022;67:314\u2013327. doi: 10.1111/adj.12934.", "ArticleIdList": ["10.1111/adj.12934", "PMC10087667", "36082517"]}, {"Citation": "Chou R., Wagner J., Ahmed A.Y., Morasco B.J., Kansagara D., Selph S., Holmes R., Fu R. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update [Internet] Agency for Healthcare Research and Quality (US); Rockville, MD, USA: 2022.", "ArticleIdList": ["36351096"]}, {"Citation": "Hall N., James B., Bhuiyan M.A.N., Crane E., Falgout C., Murnane K.S. Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain. J. Cannabis Res. 2023;5:11. doi: 10.1186/s42238-023-00179-8.", "ArticleIdList": ["10.1186/s42238-023-00179-8", "PMC10061782", "36991501"]}, {"Citation": "Iftikhar A., Zafar U., Ahmed W., Shabbir M.A., Sameen A., Sahar A., Bhat Z.F., Kowalczewski P.\u0141., Jarz\u0119bski M., Aadil R.M. Applications of Cannabis Sativa L. in Food and Its Therapeutic Potential: From a Prohibited Drug to a Nutritional Supplement. Molecules. 2021;26:7699. doi: 10.3390/molecules26247699.", "ArticleIdList": ["10.3390/molecules26247699", "PMC8708517", "34946779"]}, {"Citation": "Farinon B., Molinari R., Costantini L., Merendino N. The seed of industrial hemp (Cannabis sativa L.): Nutritional Quality and Potential Functionality for Human Health and Nutrition. Nutrients. 2020;12:1935. doi: 10.3390/nu12071935.", "ArticleIdList": ["10.3390/nu12071935", "PMC7400098", "32610691"]}, {"Citation": "Aluko R.E. Hemp Seed (Cannabis sativa L.) Proteins: Composition, Structure, Enzymatic Modification, and Functional or Bioactive Properties. In: Nadathur S.R., Wanasundara J.P.D., Scanlin L.B.T.-S.P.S., editors. Sustainable Protein Sources. Academic Press; San Diego, CA, USA: 2017. pp. 121\u2013132. Chapter 7."}, {"Citation": "Rasera G.B., Ohara A., de Castro R.J.S. Innovative and emerging applications of cannabis in food and beverage products: From an illicit drug to a potential ingredient for health promotion. Trends Food Sci. Technol. 2021;115:31\u201341. doi: 10.1016/j.tifs.2021.06.035.", "ArticleIdList": ["10.1016/j.tifs.2021.06.035"]}, {"Citation": "Dabija A., Codin\u0103 G.G., G\u00e2tlan A.M., S\u0103nduleac E.T., Rusu L. Effects of some vegetable proteins addition on yogurt quality. Sci. Study Res. Chem. Chem. Eng. Biotechnol. Food Ind. 2018;19:181\u2013192."}, {"Citation": "Korus J., Witczak M., Ziobro R., Juszczak L. Hemp (Cannabis sativa subsp. sativa) flour and protein preparation as natural nutrients and structure forming agents in starch based gluten-free bread. LWT. 2017;84:143\u2013150. doi: 10.1016/j.lwt.2017.05.046.", "ArticleIdList": ["10.1016/j.lwt.2017.05.046"]}, {"Citation": "Teterycz D., Sobota A., Przygodzka D., \u0141ysakowska P. Hemp seed (Cannabis sativa L.) enriched pasta: Physicochemical properties and quality evaluation. PLoS ONE. 2021;16:e0248790. doi: 10.1371/journal.pone.0248790.", "ArticleIdList": ["10.1371/journal.pone.0248790", "PMC7971538", "33735229"]}, {"Citation": "Schlienz N.J., Spindle T.R., Cone E.J., Herrmann E.S., Bigelow G.E., Mitchell J.M., Flegel R., LoDico C., Vandrey R. Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis. Drug Alcohol Depend. 2020;211:107969. doi: 10.1016/j.drugalcdep.2020.107969.", "ArticleIdList": ["10.1016/j.drugalcdep.2020.107969", "PMC8221366", "32298998"]}, {"Citation": "Leghissa A., Hildenbrand Z.L., Schug K.A. The imperatives and challenges of analyzing Cannabis edibles. Curr. Opin. Food Sci. 2019;28:18\u201324. doi: 10.1016/j.cofs.2019.02.010.", "ArticleIdList": ["10.1016/j.cofs.2019.02.010"]}, {"Citation": "Ascrizzi R., Iannone M., Cinque G., Marianelli A., Pistelli L., Flamini G. \u201cHemping\u201d the drinks: Aromatizing alcoholic beverages with a blend of Cannabis sativa L. flowers. Food Chem. 2020;325:126909. doi: 10.1016/j.foodchem.2020.126909.", "ArticleIdList": ["10.1016/j.foodchem.2020.126909", "32387946"]}, {"Citation": "Blake A., Nahtigal I. The evolving landscape of cannabis edibles. Curr. Opin. Food Sci. 2019;28:25\u201331. doi: 10.1016/j.cofs.2019.03.009.", "ArticleIdList": ["10.1016/j.cofs.2019.03.009"]}, {"Citation": "Cerino P., Buonerba C., Cannazza G., D\u2019Auria J., Ottoni E., Fulgione A., Di Stasio A., Pierri B., Gallo A. A Review of Hemp as Food and Nutritional Supplement. Cannabis Cannabinoid Res. 2021;6:19\u201327. doi: 10.1089/can.2020.0001.", "ArticleIdList": ["10.1089/can.2020.0001", "PMC7891210", "33614949"]}, {"Citation": "Rupasinghe H.P.V., Davis A., Kumar S.K., Murray B., Zheljazkov V.D. Industrial Hemp (Cannabis sativa subsp. sativa) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals. Molecules. 2020;25:4078. doi: 10.3390/molecules25184078.", "ArticleIdList": ["10.3390/molecules25184078", "PMC7571072", "32906622"]}, {"Citation": "Beal K. Considerations in the addition of cannabis to chocolate. Curr. Opin. Food Sci. 2019;28:14\u201317. doi: 10.1016/j.cofs.2019.02.007.", "ArticleIdList": ["10.1016/j.cofs.2019.02.007"]}, {"Citation": "Ram\u00edrez A., Viveros J.M. Brewing with Cannabis sativa vs. Humulus lupulus: A review. J. Inst. Brew. 2021;127:201\u2013209. doi: 10.1002/jib.654.", "ArticleIdList": ["10.1002/jib.654"]}, {"Citation": "Marzorati S., Friscione D., Picchi E., Verotta L. Cannabidiol from inflorescences of Cannabis sativa L.: Green extraction and purification processes. Ind. Crops Prod. 2020;155:112816. doi: 10.1016/j.indcrop.2020.112816.", "ArticleIdList": ["10.1016/j.indcrop.2020.112816"]}, {"Citation": "Paul A.A., Kumar S., Kumar V., Sharma R. Milk Analog: Plant based alternatives to conventional milk, production, potential and health concerns. Crit. Rev. Food Sci. Nutr. 2020;60:3005\u20133023. doi: 10.1080/10408398.2019.1674243.", "ArticleIdList": ["10.1080/10408398.2019.1674243", "31617734"]}, {"Citation": "Pasquali F., Schinzari M., Lucchi A., Mandrioli M., Toschi T.G., De Cesare A., Manfreda G. Preliminary data on the antimicrobial effect of Cannabis sativa L. variety Futura 75 against food-borne pathogens in vitro as well as against naturally occurring microbial populations on minced meat during storage. Ital. J. Food Saf. 2020;9:8581. doi: 10.4081/ijfs.2020.8581.", "ArticleIdList": ["10.4081/ijfs.2020.8581", "PMC7459756", "32913724"]}, {"Citation": "Langhorst J., Wulfert H., Lauche R., Klose P., Cramer H., Dobos G.J., Korzenik J. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. J. Crohns. Colitis. 2015;9:86\u2013106. doi: 10.1093/ecco-jcc/jju007.", "ArticleIdList": ["10.1093/ecco-jcc/jju007", "25518050"]}, {"Citation": "Lal S., Prasad N., Ryan M., Tangri S., Silverberg M.S., Gordon A., Steinhart H. Cannabis use amongst patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 2011;23:891\u2013896. doi: 10.1097/MEG.0b013e328349bb4c.", "ArticleIdList": ["10.1097/MEG.0b013e328349bb4c", "21795981"]}, {"Citation": "Ravikoff Allegretti J., Courtwright A., Lucci M., Korzenik J.R., Levine J. Marijuana use patterns among patients with inflammatory bowel disease. Inflamm. Bowel Dis. 2013;19:2809\u20132814. doi: 10.1097/01.MIB.0000435851.94391.37.", "ArticleIdList": ["10.1097/01.MIB.0000435851.94391.37", "PMC4126607", "24185313"]}, {"Citation": "Storr M., Devlin S., Kaplan G.G., Panaccione R., Andrews C.N. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn\u2019s disease. Inflamm. Bowel Dis. 2014;20:472\u2013480. doi: 10.1097/01.MIB.0000440982.79036.d6.", "ArticleIdList": ["10.1097/01.MIB.0000440982.79036.d6", "24407485"]}, {"Citation": "Amtmann D., Weydt P., Johnson K.L., Jensen M.P., Carter G.T. Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am. J. Hosp. Palliat. Care. 2004;21:95\u2013104. doi: 10.1177/104990910402100206.", "ArticleIdList": ["10.1177/104990910402100206", "15055508"]}, {"Citation": "Keene M.R., Heslop I.M., Sabesan S.S., Glass B.D. Perspectives of Complementary and Alternative Medicine use by cancer patients in a regional hospital in North Queensland, Australia. Complement. Ther. Med. 2022;71:102879. doi: 10.1016/j.ctim.2022.102879.", "ArticleIdList": ["10.1016/j.ctim.2022.102879", "36028116"]}, {"Citation": "Deuel L.M., Seeberger L.C. Complementary Therapies in Parkinson Disease: A Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis. Neurother. J. Am. Soc. Exp. Neurother. 2020;17:1434\u20131455. doi: 10.1007/s13311-020-00900-y.", "ArticleIdList": ["10.1007/s13311-020-00900-y", "PMC7851283", "32785848"]}, {"Citation": "Montero-Oleas N., Arevalo-Rodriguez I., Nu\u00f1ez-Gonz\u00e1lez S., Viteri-Garc\u00eda A., Simancas-Racines D. Therapeutic use of cannabis and cannabinoids: An evidence mapping and appraisal of systematic reviews. BMC Complement. Med. Ther. 2020;20:12. doi: 10.1186/s12906-019-2803-2.", "ArticleIdList": ["10.1186/s12906-019-2803-2", "PMC7076827", "32020875"]}, {"Citation": "Lall S. CBD oil. Br. Dent. J. 2020;228:395. doi: 10.1038/s41415-020-1436-7.", "ArticleIdList": ["10.1038/s41415-020-1436-7", "32221418"]}, {"Citation": "de Andrade C.M.L., Caetano T.T.V., Campos F.K., Gandra V.M., Alves F.H.F., Stein V.C. Cannabis sativa L. in the cosmeceutical industry: Prospects and biotechnological approaches for metabolite improvement. South Afr. J. Bot. 2023;161:171\u2013179. doi: 10.1016/j.sajb.2023.08.008.", "ArticleIdList": ["10.1016/j.sajb.2023.08.008"]}, {"Citation": "Britch S.C., Babalonis S., Walsh S.L. Cannabidiol: Pharmacology and therapeutic targets. Psychopharmacology. 2021;238:9\u201328. doi: 10.1007/s00213-020-05712-8.", "ArticleIdList": ["10.1007/s00213-020-05712-8", "PMC7796924", "33221931"]}, {"Citation": "Oberbarnscheidt T., Miller N.S. The Impact of Cannabidiol on Psychiatric and Medical Conditions. J. Clin. Med. Res. 2020;12:393\u2013403. doi: 10.14740/jocmr4159.", "ArticleIdList": ["10.14740/jocmr4159", "PMC7331870", "32655732"]}, {"Citation": "Volkow N.D., Weiss S.R.B. Importance of a standard unit dose for cannabis research. Addiction. 2020;115:1219\u20131221. doi: 10.1111/add.14984.", "ArticleIdList": ["10.1111/add.14984", "PMC7318599", "32083354"]}, {"Citation": "Strashny A. The CBHSQ Report. Substance Abuse and Mental Health Services Administration (US); Rockville, MD, USA: 2013. Marijuana Admissions to Substance Abuse Treatment Aged 18 to 30: Early vs. Adult Initiation; pp. 1\u20137.", "ArticleIdList": ["27631060"]}, {"Citation": "Hurd Y.L., Manzoni O.J., Pletnikov M.V., Lee F.S., Bhattacharyya S., Melis M. Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects. J. Neurosci. Off. J. Soc. Neurosci. 2019;39:8250\u20138258. doi: 10.1523/JNEUROSCI.1165-19.2019.", "ArticleIdList": ["10.1523/JNEUROSCI.1165-19.2019", "PMC6794936", "31619494"]}, {"Citation": "Bansal S., Paine M.F., Unadkat J.D. Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes. Drug Metab. Dispos. 2022;50:351\u2013360. doi: 10.1124/dmd.121.000734.", "ArticleIdList": ["10.1124/dmd.121.000734", "35115300"]}, {"Citation": "Nasrin S., Watson C.J.W., Perez-Paramo Y.X., Lazarus P. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Drug Metab. Dispos. 2021;49:1070\u20131080. doi: 10.1124/dmd.121.000442.", "ArticleIdList": ["10.1124/dmd.121.000442", "34493602"]}, {"Citation": "Prandi C., Blangetti M., Namdar D., Koltai H. Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases. Molecules. 2018;23:1526. doi: 10.3390/molecules23071526.", "ArticleIdList": ["10.3390/molecules23071526", "PMC6099582", "29941830"]}, {"Citation": "Troup L.J., Erridge S., Ciesluk B., Sodergren M.H. Perceived Stigma of Patients Undergoing Treatment with Cannabis-Based Medicinal Products. Int. J. Environ. Res. Public Health. 2022;19:7499. doi: 10.3390/ijerph19127499.", "ArticleIdList": ["10.3390/ijerph19127499", "PMC9223559", "35742748"]}, {"Citation": "Casarett D., Abrams D.I. Why Insurance Companies Should Pay for Medical Cannabis. Am. J. Bioeth. 2019;19:8\u201310. doi: 10.1080/15265161.2019.1567193.", "ArticleIdList": ["10.1080/15265161.2019.1567193", "30994419"]}, {"Citation": "Sagy I., Peleg-Sagy T., Barski L., Zeller L., Jotkowitz A. Ethical issues in medical cannabis use. Eur. J. Intern. Med. 2018;49:20\u201322. doi: 10.1016/j.ejim.2018.01.016.", "ArticleIdList": ["10.1016/j.ejim.2018.01.016", "29482739"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "29"}, {"Year": "2023", "Month": "11", "Day": "9"}, {"Year": "2023", "Month": "11", "Day": "15"}, {"Year": "2023", "Month": "12", "Day": "17", "Hour": "9", "Minute": "43"}, {"Year": "2023", "Month": "12", "Day": "9", "Hour": "10", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "9", "Hour": "1", "Minute": "4"}, {"Year": "2023", "Month": "11", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["38067416", "PMC10707504", "10.3390/molecules28237686", "molecules28237686"]}}], "PubmedBookArticle": []}